Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ITIH5 encodes a heavy chain component of one of the inter-alpha-trypsin inhibitor (ITI) family members. Additionally we are shipping ITIH5 Kits (8) and ITIH5 Proteins (6) and many more products for this protein.
Showing 10 out of 27 products:
Human Polyclonal ITIH5 Primary Antibody for EIA, IHC (p) - ABIN952964
Pita, Banito, Cavaco, Leite: Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas. in British journal of cancer 2009
Show all 3 references for ABIN952964
indicate an additional and specific role of this gene in the female reproductive tract, and furthermore reinforces ITIH5 as a putative candidate gene for MRKH syndrome.
ITIH5 may be a novel putative tumor suppressor gene in NSCLC with a potential molecular significance in the squamoid ADC (show ADC Antibodies) subtype and further clinical impact for risk stratification of adenocarcinoma patients.
Hence, we can strengthen the presumption that ITIH5 may constitute a novel regulatory molecule of the human skin that could play an important role in in fl ammation via its interaction with hyaluronic acid.
ITIH5 expression is decreased in gastric cancer and that low expression of this protein is associated with poor clinical outcome.
ITIH5 is a novel putative tumor suppressor gene in colon cancer with a potential impact in the CIMP-related pathway.
Tumor-specific methylation of the three-gene panel (ITIH5, DKK3, and RASSF1A (show RASSF1 Antibodies)) might be a valuable biomarker for the early detection of breast cancer.
provide evidence that down-regulation of ITIH5 by aberrant DNA hypermethylation may provoke invasive phenotypes in human bladder cancer
ITIH5 gene expression is regulated both by obesity and by the region between visceral and subcutaneous adipose tissue.
ITIH-5 is highly expressed in sc adipose tissue, increased in obesity, down regulated after weight loss, and associated with measures of body size and metabolism.
expression is consistantly lost or strongly downregulated in invasive ductal carcinoma; proposed that loss of ITIH5 expression may be involved in breast cancer development
Promoter methylation-mediated loss of ITIH5 expression is associated with unfavourable outcome in breast cancer patients.
This gene encodes a heavy chain component of one of the inter-alpha-trypsin inhibitor (ITI) family members. ITI proteins are involved in extracellular matrix stabilization and in the prevention of tumor metastasis. They are also structurally related plasma serine protease inhibitors and are composed of a light chain and varying numbers of heavy chains. This family member is thought to function as a tumor suppressor in breast and thyroid cancers. Alternative splicing results in multiple transcript variants.
ITI heavy chain H5
, inter-alpha trypsin inhibitor heavy chain precursor 5
, inter-alpha-inhibitor heavy chain 5
, inter-alpha-trypsin inhibitor heavy chain H5
, inter-alpha (globulin) inhibitor H5
, inter-alpha trypsin inhibitor heavy chain 5